Category: 44. TCT@ACC-i2: Translation and Pre-clinical Research
substAntiAl VAriAbility betWeen lAborAtories in troPonin Decision leVel for DiAgnosis of MyocArDiAl infArction AnD AssAy 99th Percentile: finDings froM the internAtionAl stuDy of coMPArAtiVe heAlth effectiVeness With MeDicAl AnD inVAsiVe APProAches (ischeMiA) triAl background: The Third Universal Definition of Myocardial Infarction (MI) designates an increase in cardiac troponin concentration (cTn) > 99th percentile of a normal reference population as the decision level for MI diagnosis. The variability among hospitals in the lab-determined cTn level to diagnose MI [cTn decision level] relative to the assay manufacturer determined 99th percentile has not been well characterized.
Methods:
We surveyed 93 sites from 15 countries participating in the NHLBI ISCHEMIA trial to ascertain the cTn assay used at their hospital labs, its 99th percentile, as well as the cTn MI decision level. The ratio of cTn MI decision level to cTn 99th percentile was calculated for each lab.
results: Laboratories employed 32 unique cTn assays from 7 manufacturers; 77% used cTnI assays and 23% used cTnT assays. Highly sensitive assays were used in 18 labs (19.4%). The ratio of cTn MI decision level to cTn 99th percentile was <1 at 7 labs (7.5%), equal to 1 at 29 labs (31.2%) and >10 at 18 labs (19.4%) (Figure) . Substantial variability was observed in cTn MI decision level even among labs using the same assay.
conclusion: Significant variability exists in the cTn MI decision level used by hospital laboratories relative to the assay cTn 99th percentile. Only one-third of labs follow the Third Universal Definition of MI. These data have important implications for the diagnosis of MI in clinical practice and adjudicating MI endpoints in clinical trials. Figure: 
